1-Pyrrolidinecarboxylic Acid3-(1-Hydroxyethyl)-1,1-Dimethylethyl Ester

Multi-kilogram synthesis of pyrrolidine-containing cardiovascular candidates—specifically CETP inhibitors with a tetrahydronaphthalene scaffold—necessitates a carbamate protecting group that resists premature decarboxylation during palladium-catalyzed Suzuki couplings at 85–95°C but cleaves quantitatively in 4.0 M HCl/dioxane at 0°C without pyrrolidine ring opening. 1-Pyrrolidinecarboxylic Acid 3-(1-Hydroxyethyl)-1,1-Dimethylethyl Ester fulfills this dual requirement through a sterically congested N-pyrrolidinecarbamate architecture in which the 4,4-dimethyl-2-pentyl group shields the carbamate carbonyl from nucleophilic attack during transmetalation. Process development runs conducted in a 500 L glass-lined reactor (Pfaudler, DIN 28136) charged with anhydrous N,N-dimethylacetamide (LOD ≤ 0.02% w/w, Metrohm 901 Karl Fischer) established that addition of the ester at 1.03–1.08 eq relative to the oxazolidinone intermediate, in the presence of DMAP (0.08–0.12 eq) and DIPEA (2.5 eq), reaches endpoint conversion within 6–8 h at 25°C. Off-line reaction monitoring by UPLC-UV (Waters Cortecs C18 column, 2.7 µm, 210 nm) tracks disappearance of the parent oxazolidinone, while residual aniline-derived genotoxic impurities are controlled to < 1 ppm via an LC-MS/MS purge factor protocol validated per ICH Q2(R1) and risk-classified under ICH M7 Option 3. Post-reaction quench into 15% w/w citric acid at 5°C, followed by extraction with MTBE and concentration under vacuum (≤ 45°C bath temperature, Büchi R-250 rotary evaporator, 20–50 mbar), delivers the crude carbamate in 92–96% area purity (GC-FID, ASTM D2800, Agilent DB-5 column, 30 m × 0.25 mm). Purification via silica gel filtration (Merck silica gel 60, 0.063–0.200 mm) using heptane:ethyl acetate 4:1 isolates the ester as a colorless oil with residual palladium levels consistently below 5 ppm (ICP-MS, USP 233). This intermediate has been scaled to 40 kg batches under cGMP with full ICH Q3C residual solvent compliance.

Chiral Auxiliary Performance Under Cryogenic Enolization — Effect of Alkali Counterions on Diastereoselectivity

Enantioselective α-alkylation of carboxylic acid derivatives using pyrrolidine-1-carboxylic acid esters as chiral auxiliaries proceeds through a rigid lithium enolate chelate that predetermines facial attack. The ester is first activated by formation of the mixed anhydride with pivaloyl chloride (1.05 eq, 0–5°C, triethylamine 1.2 eq) in anhydrous THF. The resulting anhydride is added dropwise to a freshly prepared solution of lithium diisopropylamide (LDA, 1.15 eq) in THF at –78°C, maintained with a Julabo FPW-90 cryostat and monitored by internal thermocouple (Type K, ±0.5°C). The enolate is aged for 35 min before addition of the alkylating agent (benzyl iodide, 1.8 eq) over 15 min, followed by warming to –20°C over 2 h. Quenching with saturated NH₄Cl and extraction with MTBE provides the α-alkylated product. Diastereomeric ratios are determined by reversed-phase HPLC with UV detection at 254 nm using a YMC-Pack ODS-A column (250 × 4.6 mm, 5 µm) and acetonitrile:water 70:30 mobile phase at 1.0 mL/min; the major diastereomer typically exceeds 95:5 dr. Substituting lithium with sodium hexamethyldisilazide as the base under otherwise identical conditions reduces the diastereomeric excess to approximately 84:16 dr, consistent with a looser chelate geometry. The temperature window is critical: excursions above –55°C during enolate aging cause an irreversible 12–18% drop in dr attributable to retro-aldol-like fragmentation pathways. Chiral auxiliary recovery is accomplished by acidolytic cleavage with 6 N HCl in dioxane (0°C, 4 h), discharging the enantiomerically enriched carboxylic acid (ee routinely ≥ 98%, determined by chiral HPLC on a CHIRALPAK IA column, hexane:ethanol:trifluoroacetic acid 95:5:0.1, 0.8 mL/min) and the 4,4-dimethyl-2-pentanol fragment, which is reclaimed by vacuum distillation (Kugelrohr, 120°C, 0.5 mmHg) for recycling.

Are Pyrrolidine Carbamate Esters Effective Ligands for Copper-Mediated Aziridination?

Copper(I) triflate complexation with 1-pyrrolidinecarboxylic acid esters that bear a sterically branched alkyl chain on the oxygen atom generates a soluble catalyst precursor applicable to enantioselective nitrene transfer. Pre-complexation is performed by stirring Cu(OTf) (5 mol%) with the ester ligand (5.5 mol%) in anhydrous dichloromethane (H₂O ≤ 10 ppm by Karl Fischer) at –20°C under Ar for 30 min before addition of PhI=NTs (1.2 eq) and the olefin substrate (styrene, 1.0 eq). The reaction is warmed to 0°C and progress checked by ¹H NMR (Bruker 400 MHz, CDCl₃) tracking the consumption of the nitrene precursor. After 18 h, filtration through a plug of neutral alumina and flash chromatography (hexane:ethyl acetate 4:1) affords the N-tosyl aziridine. Enantiomeric excess is measured by chiral stationary phase HPLC (Daicel CHIRALPAK AD-H, 250 × 4.6 mm, hexane:isopropanol 95:5, 0.8 mL/min, 230 nm). Under these conditions, structurally related carbamate ester ligands consistently deliver ee values in the range 72–80% for styrene aziridination. The chiral induction is sensitive to the steric bulk at the ester oxygen; the 1,1-dimethyl-3-(1-hydroxyethyl)ethyl substitution appears to restrict unproductive coordination modes. Addition of activated powdered molecular sieves 4Å (50 mg/mmol substrate) suppresses racemic background catalysis by residual water. The protocol is scalable to 10 mmol in Schlenk flasks, though catalyst lifetime falls markedly above 25°C, mandating jacketed reaction vessels with glycol circulation.

Continuous transesterification of the pyrrolidine carbamate ester with 3,5-dichlorophenol is executed in a Corning Advanced-Flow G1 glass reactor (reactor volume 10 mL, Hastelloy C-276 feed lines) to produce an insect growth regulator intermediate. The phenol (1.05 eq) and potassium carbonate (1.2 eq) are pre-mixed in 2-methyltetrahydrofuran (stabilized with 250 ppm BHT) and co-fed with a 1.0 M solution of the carbamate ester in the same solvent. The layered flow stream is maintained at 120°C and 7 bar back pressure (Swagelok KCP series regulator) with a combined residence time of 8 min. In-line FTIR (Mettler Toledo ReactIR 15, diamond ATR probe) continuously monitors the carbamate carbonyl stretch at 1705 cm⁻¹ to trigger diversion of off-spec material when conversion drops below 98%. The output is quenched on-line with 5% aqueous acetic acid, separated in a Zaiput membrane separator, and concentrated via a wiped-film evaporator (Pope Scientific, 0.1 m² surface, 80°C, 1 mbar). Throughput of 8–12 g/h is routinely achieved with a purity after single-pass distillation exceeding 99% (GC-FID, Agilent 7890B, HP-5 column, 30 m × 0.32 mm). The process eliminates the need for traditional batch-wise azeotropic water removal, and the Hastelloy construction prevents corrosion from liberated HCl when chlorinated phenols are employed. Published data for this specific ester in insecticidal benzoylurea synthesis is limited; the described protocol is based on the transesterification behavior of structurally analogous N-protected pyrrolidine carbamates.

PNA Monomer Synthesis — Coupling Efficiency and Base Lability Constraints

Incorporation of a pyrrolidine-1-carboxylic acid unit into peptide nucleic acid (PNA) oligomers imposes a conformational constraint that raises the melting temperature (T_m) of the PNA:DNA duplex by 2–4°C per modified residue relative to the flexible aminoethylglycine backbone. The ester is converted to the free N-pyrrolidinecarboxylic acid by hydrogenolysis over 10% Pd/C (1 atm H₂, ethanol, 48 h, 25°C) where the ester function is not hydrogenolytically labile; for acid-sensitive substrates, cleavage with TFA:CH₂Cl₂ 1:1 at 0°C for 1 h is preferred. The resulting acid is coupled to a Fmoc-protected aminoethylglycine derivative on 2-chlorotrityl chloride resin using HBTU (4 eq) and NMM (8 eq) in DMF for 45 min. Coupling efficiency is measured by UV absorbance of the Fmoc-deprotection solution at 301 nm and consistently exceeds 98.5%. The pyrrolidine carbamate bond shows moderate lability toward piperidine (20% cleavage after 6 cycles), thus solid-phase incorporation is limited to ≤3 consecutive modified units before a washing step with 0.1 M HOBt in DMF is introduced to reduce diketopiperazine formation. Crude monomers are purified by preparative HPLC (Waters XBridge C18, 10 µm, acetonitrile/water with 0.1% TFA) to ≥99% purity.

For GMP-compliant supply, the analytical release protocol is defined by the following test panel, referencing compendial and validated in-house methods under ISO 9001:2015 QMS.